The 5-Hydroxytryptamine Receptor 1D pipeline drugs market research report outlays comprehensive information on the 5-Hydroxytryptamine Receptor 1D targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the 5-Hydroxytryptamine Receptor 1D pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Central Nervous System, and Mouth and Dental Disorders which include the indications Migraine, Cluster Headache Syndrome (Cluster Headache), and Mouth and Dental Disorders. It also reviews key players involved in 5-Hydroxytryptamine Receptor 1D targeted therapeutics development with respective active and dormant or discontinued products.
The 5-Hydroxytryptamine Receptor 1D pipeline targets constitutes close to 16 molecules. Out of which, approximately 16 molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Pre-Registration, Filing rejected/ Withdrawn, Phase III, Phase II, Phase I, IND/ CTA Filed, and Preclinical stages are 3, 2, 2, 2, 2, 1, and 4 respectively.
5-Hydroxytryptamine Receptor 1D overview
HTR1D is a 5-hydroxytryptamine (serotonin) receptor. The activity of this receptor is mediated by G proteins, which inhibits adenylate cyclase. The HTR1D receptor also acts as a receptor for ergot alkaloid derivatives, anxiolytic and antidepressant medications, and other psychotropic compounds.
For a complete picture of 5-Hydroxytryptamine Receptor 1D’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.